✦ LIBER ✦

Cost-efficacy of adalimumab, etanercept, infliximab and ustekinumab for moderate-to-severe plaque psoriasis

✍ Scribed by C. Ferrándiz; A. García; A.J. Blasco; P. Lázaro

Book ID: 111098931
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 242 KB
Volume: 26
Category: Article
ISSN: 0926-9959
DOI: 10.1111/j.1468-3083.2011.04357.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost per treated patient for etanercept

Cost per treated patient for etanercept and ustekinumab in patients treated for moderate to severe plaque psoriasis

📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Comparison of Ustekinumab and Etanercept

Comparison of Ustekinumab and Etanercept for Moderate-to-Severe Psoriasis

✍ Griffiths, Christopher E.M.; Strober, Bruce E.; van de Kerkhof, Peter; Ho, Vince 📂 Article 📅 2010 🏛 Massachusetts Medical Society 🌐 English ⚖ 411 KB

Ustekinumab useful for moderate-to-sever

Ustekinumab useful for moderate-to-severe plaque psoriasis

📂 Article 📅 2008 🏛 Adis International Limited (now part of Wolters Kl ⚖ 195 KB

Cost per responder with adalimumab versu

Cost per responder with adalimumab versus ustekinumab treatment for moderate to severe psoriasis with suboptimal response to etanercept

📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 50 KB

PSS8 COST EFFICACY OF USTEKINUMAB IN TRE

PSS8 COST EFFICACY OF USTEKINUMAB IN TREATMENT OF MODERATE TO SEVERE PLAQUE PSORIASIS IN TURKEY

✍ M Tatar; F Sarioz 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB

PSY27 Cost Effectiveness of Treatment Wi

PSY27 Cost Effectiveness of Treatment With Etanercept or Ustekinumab for Moderate to Severe Psoriasis

✍ R. Villacorta; J. Hay; A. Messali 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB